Wei Yan received B.A. degree in Biology in 2009 from Ocean University of China, Qingdao. She then entered a doctoral program at Shanghai Institute of Biochemistry and Cell Biology
Our research team employs interdisciplinary methods, encompassing structural biology, cell biology, and medicinal chemistry, to unravel the molecular basis of channelopathies and explore diverse modes of action for drugs targeting ion channels.
Miao Yu is a Professor of Cell Biology at the College of Life Sciences, Wuhan University, and serves as the principal investigator at the Taikang Life Sciences Center. She obtained her Bachelor's degree in Acoustics from Nanjing University and her Ph.D. in Bioengineering from the Hong Kong University of Science and Technology. In 2019, she was honored ...
Prof. Yu, MD, Ph.D., is first class chief physician, third class professor, and doctoral supervisor. He is vice president of Renmin Hospital of Wuhan University, vice president of Cardiovascular Hospital of Renmin Hospital of Wuhan University, and executive director of Hubei Key Laboratory of Autonomic Nervous System Modulation.research Innovative research and clinical technology development for cardiovascular diseases
Professor Yuan Yufeng and his team focus on the pathogenesis of primary liver cancer and metabolic liver disease, as well as the research of the early diagnosis and minimally invasive treatment of hepatobiliary and Pancreatic tumors
Diseases caused by infectious pathogens, particularly with multi-drug resistant properties, have become a major threat to public health around the world, thus new antibiotics with novel structures and mode of actions are urgently needed. Natural products have been a valuable source of therapeutics particularly in the areas of infectious disease. However, discovering novel natural products has become significantly more difficult.
